Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Subcutaneous vaccine administration – an outmoded practice
Ian F. Cook
Human Vaccines & Immunotherapeutics (2020) Vol. 17, Iss. 5, pp. 1329-1341
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Adverse effects following anti–COVID-19 vaccination with mRNA-based BNT162b2 are alleviated by altering the route of administration and correlate with baseline enrichment of T and NK cell genes
Ayesa Syenina, Esther S. Gan, Justin Z. N. Toh, et al.
PLoS Biology (2022) Vol. 20, Iss. 5, pp. e3001643-e3001643
Open Access | Times Cited: 30
Clinical perspective on topical vaccination strategies
Petya Popova, Sunny P. Chen, Suiyang Liao, et al.
Advanced Drug Delivery Reviews (2024) Vol. 208, pp. 115292-115292
Open Access | Times Cited: 6
mRNA vaccine designs for optimal adjuvanticity and delivery
Yuki Mochida, Satoshi Uchida
RNA Biology (2024) Vol. 21, Iss. 1, pp. 1-27
Open Access | Times Cited: 5
What variables should inform needle length choice for deltoid intramuscular injection? A systematic review
Ciléin Kearns, Claire Houghton, Emily Dickinson, et al.
BMJ Open (2023) Vol. 13, Iss. 1, pp. e063530-e063530
Open Access | Times Cited: 9
Precision Vaccinology Approaches for the Development of Adjuvanted Vaccines Targeted to Distinct Vulnerable Populations
Branden Lee, Etsuro Nanishi, Ofer Levy, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1766-1766
Open Access | Times Cited: 7
Stability of Protein Pharmaceuticals: Recent Advances
Mark C. Manning, Ryan E. Holcomb, R. W. Payne, et al.
Pharmaceutical Research (2024) Vol. 41, Iss. 7, pp. 1301-1367
Closed Access | Times Cited: 2
Nanotechnology platforms for antigen and immunostimulant delivery in vaccine formulations
P Márquez, Federico Javier Wolman, Romina J. Glisoni
Nano Trends (2024) Vol. 8, pp. 100058-100058
Open Access | Times Cited: 2
Inadvertent subcutaneous injection of COVID-19 vaccine
Jia Ng
Postgraduate Medical Journal (2021) Vol. 97, Iss. 1148, pp. 400-400
Open Access | Times Cited: 17
Inadequate deltoid muscle penetration and concerns of improper COVID mRNA vaccine administration can be avoided by injection technique modification
Nimrod Rahamimov, Veronica Baturov, Adi Shani, et al.
Vaccine (2021) Vol. 39, Iss. 37, pp. 5326-5330
Open Access | Times Cited: 16
A comparative analysis on the safety and efficacy of Covaxin versus other vaccines against COVID-19: a review
Abhijita Talukder, Chayanika Kalita, Nayanika Neog, et al.
Zeitschrift für Naturforschung C (2022) Vol. 77, Iss. 7-8, pp. 351-362
Open Access | Times Cited: 10
Immunogenicity of Intradermal Versus Intramuscular BNT162b2 COVID-19 Booster Vaccine in Patients with Immune-Mediated Dermatologic Diseases: A Non-Inferiority Randomized Controlled Trial
Chutima Seree-aphinan, Ploysyne Rattanakaemakorn, Poonkiat Suchonwanit, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 73-73
Open Access | Times Cited: 1
Intramuscular vaccination needle length: a call to arms
Marjan Doppen, Ciléin Kearns, Thomas Hills, et al.
The Lancet (2024) Vol. 403, Iss. 10426, pp. 528-529
Open Access | Times Cited: 1
Feasibility of Using a Type I IFN-Based Non-Animal Approach to Predict Vaccine Efficacy and Safety Profiles
Hanin Abdel–Haq
Vaccines (2024) Vol. 12, Iss. 6, pp. 583-583
Open Access | Times Cited: 1
Safety of intramuscular COVID‐19 vaccination in patients with haemophilia
Andreas Tiede, Hendrik Leise, Silvia Horneff, et al.
Haemophilia (2022) Vol. 28, Iss. 5, pp. 687-693
Open Access | Times Cited: 7
Meeting vaccine formulation challenges in an emergency setting: Towards the development of accessible vaccines
Allegra Peletta, Céline Lemoine, Thomas Courant, et al.
Pharmacological Research (2023) Vol. 189, pp. 106699-106699
Open Access | Times Cited: 4
The effect of needle length and skin to deltoid muscle distance in adults receiving an mRNA COVID-19 vaccine
Thomas Hills, Aimee Paterson, Rebecca M Woodward, et al.
Vaccine (2022) Vol. 40, Iss. 33, pp. 4827-4834
Open Access | Times Cited: 7
Intramuscular Inoculation of AS02-Adjuvanted Respiratory Syncytial Virus (RSV) F Subunit Vaccine Shows Better Efficiency and Safety Than Subcutaneous Inoculation in BALB/c Mice
Lijun Bian, Yu Zheng, Xiaohong Guo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
Skin as an immune organ and the site of biomimetic, non-invasive vaccination
Amla Chopra, Archi Gupta
Medicine in Novel Technology and Devices (2022) Vol. 16, pp. 100196-100196
Open Access | Times Cited: 6
Preclinical developments in the delivery of protein antigens for vaccination
Dylan A. Hendy, Alex Haven, Eric M. Bachelder, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 3, pp. 367-384
Open Access | Times Cited: 3
When should a longer needle be used for intramuscular injection in obese patients? A combined analysis of New Zealand data
Marjan Doppen, Ciléin Kearns, Mark Weatherall, et al.
Vaccine (2023) Vol. 41, Iss. 16, pp. 2690-2695
Open Access | Times Cited: 3
Alcaligenes lipid A functions as a superior mucosal adjuvant to monophosphoryl lipid A via the recruitment and activation of CD11b+ dendritic cells in nasal tissue
Xiao Sun, Koji Hosomi, Atsushi Shimoyama, et al.
International Immunology (2023) Vol. 36, Iss. 1, pp. 33-43
Open Access | Times Cited: 3
An injectable subcutaneous colon-specific immune niche for the treatment of ulcerative colitis
Kin Man Au, Justin E. Wilson, Jenny P.-Y. Ting, et al.
Nature Biomedical Engineering (2023) Vol. 8, Iss. 10, pp. 1243-1265
Open Access | Times Cited: 3
Subcutaneous injection of mRNA vaccines against severe acute respiratory syndrome coronavirus 2: an option for severe bleeding disorders or anticoagulated patients?
Matthias Karer, Karin Stiasny, Markus Zeitlinger, et al.
Blood Coagulation & Fibrinolysis (2021) Vol. 32, Iss. 6, pp. 423-424
Open Access | Times Cited: 7
Safety and immunogenicity of a 15-valent pneumococcal conjugate vaccine in Japanese healthy infants: A Phase I study (V114-028)
Yasunori Ishihara, Haruo Kuroki, Hidenobu Hidaka, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Dose-sparing effect of Sabin-derived inactivated polio vaccine produced in Japan by intradermal injection device for rats
Eriko Itoh, Sakiko Shimizu, Yasushi Ami, et al.
Biologicals (2023) Vol. 82, pp. 101677-101677
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top